'BioNTech Scare Evidence Has All Been Dumped'
"); jQuery("#212 h3").html("

"); });
2021-03-26 HKT 12:54
A co-chairman of the Medical Association's advisory committee on communicable diseases says he can't understand why the authorities threw away shots of BioNTech's coronavirus vaccine that had defective packaging, saying this must have hampered an investigation into the suspected problem.
The Hong Kong government suspended use of the jabs on Wednesday, saying that on 57 occasions, frontline vaccination workers had reported problems, including cracks in containers, loose caps, and stains or marks on the outside of bottles.
The Director of Health, Constance Chan, said the problematic doses had been dumped.
She also announced that mainland company Fosun, which distributes the BioNTech vaccine in the Greater China region, would be carrying out an immediate investigation, including a review of the whole logistics chain.
But on RTHK's Backchat programme on Friday morning, Dr Alvin Chan warned that the "evidence" appears to have been destroyed.
"I am quite surprised that the Hong Kong authorities said that they had already discarded all the problematic bottles, or the vials of vaccine, when they were detected to be faulty. That means we don't have those bottles as evidence for the company of BioNTech to check what had happened," he said.
"To investigate the problem, at least these faulty bottles need to be examined meticulously by the company ... to really solve the conundrum."
The doctor added that he was happy to hear that at least the suspect doses were not given to members of the public.
Despite the suspension, the government and BioNTech have both said that don't believe there is any safety issue involving the batch of vaccines in question. More than 150,000 Hongkongers have received shots from this batch.
“At this point, we have no reason to believe there is any safety risk posed to the population,” BioNTech said in a statement on Wednesday.
Speaking on the same radio show on Friday, Dr Henry Yeung a former president of Hong Kong Doctors' Union, agreed that the government was right to suspend the use of BioNTech jabs until an investigation is completed.
"Safety is the most important concern of the government and the medical profession. I think we have to ask the factory to look into the matter from all angles before we can continue the jab again," Yeung said.
"For me, I think both BioNTech and Sinovac are pretty safe for use ... I'm going to receive the second jab of the Sinovac today. I have full trust in those two vaccines."
ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education
ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more
Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets
The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more
Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation
Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more
MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending
MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more
Why The $2 Trillion Stablecoin Prediction Is Too Low
McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more
RedotPay Eyes US IPO With Potential US$1 Billion Raise
RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more
